Affiliation: Mount Sinai School of Medicine
- A review of pharmacologic treatments for obsessive-compulsive disorderAlicia Kaplan
Department of Psychiatry, Mount Sinai Scjhool of Medicine, New York, New York 10029, USA
Psychiatr Serv 54:1111-8. 2003..In this article the authors review studies of pharmacologic treatments...
- Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander
Mt Sinai School of Medicine, One Gustave Levy Place, Box 1230, NY, NY 10029, USA
J Neuropsychiatry Clin Neurosci 17:472-7. 2005..These subtle neurological abnormalities may implicate a potential subgroup of OCD patients with poorer treatment response. This may have treatment implications and therefore serve as a screening tool in OCD...
- Comorbidity in compulsive hoarding: a case reportAlicia Kaplan
Department of Psychiatry, Mount Sinai School of Medicine, New York City, New York 10029 6574, USA
CNS Spectr 9:71-3. 2004..Augmentation with stimulants may provide benefits in aspects of hoarding such as procrastination, especially in patients with comorbid attention-deficit hyperactivity disorder...
- An open-label trial of venlafaxine in body dysmorphic disorderAndrea Allen
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:138-44. 2008..This open-label trial examines venlafaxine's efficacy in BDD and is the first known study of this serotonin-norepinephrine reuptake inhibitor in BDD...
- A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorderEric Hollander
Department, of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, USA
World J Biol Psychiatry 4:30-4. 2003..Its effectiveness in specific subgroups of OCD patients with co-morbid anxiety disorders or as an augmentation strategy added to SSRIs remains to be determined...